FDA Acting Chief Counsel To Be Masoudi
This article was originally published in The Pink Sheet Daily
Executive Summary
Dan Troy will leave agency Nov. 24 after three years which included major Waxman/Hatch reforms and reconsideration of First Amendment issues. Newly appointed deputy chief counsel Masoudi will succeed Troy until a permanent chief counsel is selected by HHS’ Azar.